342 related articles for article (PubMed ID: 34342837)
1. Pituitary metastases from neuroendocrine neoplasms: case report and narrative review.
Ragni A; Nervo A; Papotti M; Prencipe N; Retta F; Rosso D; Cacciani M; Zamboni G; Zenga F; Uccella S; Cassoni P; Gallo M; Piovesan A; Arvat E
Pituitary; 2021 Oct; 24(5):828-837. PubMed ID: 34342837
[TBL] [Abstract][Full Text] [Related]
2. Limited Value of Ga-68-DOTATOC-PET-CT in Routine Screening of Patients with Multiple Endocrine Neoplasia Type 1.
Albers MB; Librizzi D; Lopez CL; Manoharan J; Apitzsch JC; Slater EP; Bollmann C; Kann PH; Bartsch DK
World J Surg; 2017 Jun; 41(6):1521-1527. PubMed ID: 28138732
[TBL] [Abstract][Full Text] [Related]
3. Added value of [
Yoo J; Kim SH; Jeon SK; Bae JS; Han JK
Eur Radiol; 2021 Oct; 31(10):7734-7745. PubMed ID: 33787974
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
[No Abstract] [Full Text] [Related]
5. The Correlation Between [
Yu J; Li N; Li J; Lu M; Leal JP; Tan H; Su H; Fan Y; Zhang Y; Zhao W; Zhu H; Pomper MG; Zhou Y; Yang Z
Mol Imaging Biol; 2019 Oct; 21(5):984-990. PubMed ID: 30796708
[TBL] [Abstract][Full Text] [Related]
6. Limited role of carbidopa-assisted
Imperiale A; Averous G; Helali M; Taieb D; Pessaux P; Goichot B; Addeo P; Bachellier P
Ann Nucl Med; 2019 Sep; 33(9):697-707. PubMed ID: 31214959
[TBL] [Abstract][Full Text] [Related]
7. The rare entity of bilateral and unilateral neuroendocrine metastases to the breast: a case series and literature review.
Zagami P; Kandaraki E; Renne G; Grimaldi F; Spada F; Laffi A; Fazio N
Ecancermedicalscience; 2020; 14():1123. PubMed ID: 33209114
[TBL] [Abstract][Full Text] [Related]
8. Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs).
Effraimidis G; Knigge U; Rossing M; Oturai P; Rasmussen ÅK; Feldt-Rasmussen U
Semin Cancer Biol; 2022 Feb; 79():141-162. PubMed ID: 33905872
[TBL] [Abstract][Full Text] [Related]
9. Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers.
Giannetta E; Sesti F; Modica R; Grossrubatscher EM; Guarnotta V; Ragni A; Zanata I; Colao A; Faggiano A
Front Endocrinol (Lausanne); 2021; 12():665698. PubMed ID: 34093441
[TBL] [Abstract][Full Text] [Related]
10. Preclinical drug studies in MEN1-related neuroendocrine neoplasms (MEN1-NENs).
Grozinsky-Glasberg S; Lines KE; Avniel-Polak S; Bountra C; Thakker RV
Endocr Relat Cancer; 2020 Sep; 27(9):R345-R355. PubMed ID: 32590358
[TBL] [Abstract][Full Text] [Related]
11. Radiology of the neuroendocrine neoplasms of the gastrointestinal tract: a comprehensive review.
Malla S; Kumar P; Madhusudhan KS
Abdom Radiol (NY); 2021 Mar; 46(3):919-935. PubMed ID: 32960304
[TBL] [Abstract][Full Text] [Related]
12. Metastatic involvement of the pituitary gland: a systematic review with pooled individual patient data analysis.
He W; Chen F; Dalm B; Kirby PA; Greenlee JD
Pituitary; 2015 Feb; 18(1):159-68. PubMed ID: 24445565
[TBL] [Abstract][Full Text] [Related]
13. Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients.
Zhang J; Kulkarni HR; Singh A; Niepsch K; Müller D; Baum RP
J Nucl Med; 2019 Mar; 60(3):377-385. PubMed ID: 30115686
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
[TBL] [Abstract][Full Text] [Related]
15. Orbital metastases from neuroendocrine neoplasms: clinical implications and outcomes.
Kamieniarz L; Armeni E; O'Mahony LF; Leigh C; Miah L; Narayan A; Bhatt A; Cox N; Mandair D; Navalkissoor S; Caplin M; Toumpanakis C
Endocrine; 2020 Feb; 67(2):485-493. PubMed ID: 31732922
[TBL] [Abstract][Full Text] [Related]
16. High Metabolic Tumour Volume on 18-Fluorodeoxyglucose Positron Emission Tomography Predicts Poor Survival from Neuroendocrine Neoplasms.
Chan DL; Bernard EJ; Schembri G; Roach PJ; Johnson M; Pavlakis N; Clarke S; Bailey DL
Neuroendocrinology; 2020; 110(11-12):950-958. PubMed ID: 31711058
[TBL] [Abstract][Full Text] [Related]
17. Ocular adnexal manifestations of neuroendocrine neoplasms: a case report and a major review.
Hatsis AJ; Henry RK; Curtis MT; Bilyk JR; Sivalingam MD; Eagle RC; Milman T
Orbit; 2021 Dec; 40(6):488-498. PubMed ID: 33140682
[TBL] [Abstract][Full Text] [Related]
18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal neuroendocrine neoplasms (GI-NENs): hot topics in morphological, functional, and prognostic imaging.
Danti G; Flammia F; Matteuzzi B; Cozzi D; Berti V; Grazzini G; Pradella S; Recchia L; Brunese L; Miele V
Radiol Med; 2021 Dec; 126(12):1497-1507. PubMed ID: 34427861
[TBL] [Abstract][Full Text] [Related]
20. Extended Survival After Surgical Resection for Pituitary Metastases: Clinical Features, Management, and Outcomes of Metastatic Disease to the Sella.
Patel KR; Zheng J; Tabar V; Cohen MA; Girotra M
Oncologist; 2020 May; 25(5):e789-e797. PubMed ID: 31784491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]